S100A8 and Myocardial fibrosis: As a well-established biomarker of cardiovascular disease, S100A8/A9 exacerbates cardiac injury by promoting inflammation, causing mitochondrial dysfunction, driving myocardial fibrosis, and promoting apoptosis and autophagy.